Gün + Partners
Practitioners reveal how changes to non-use cancellations, first outlined in 2017 but yet to be formalised, are affecting their strategies
Sponsored
Sponsored
-
Sponsored by Gün + PartnersSelin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D -
Sponsored by Gün + PartnersBarış Kalaycı and Direnç Bada of Gün and Partners discuss an IP case that led to the discovery, and removal, of fake fire-resistant glass from hospitals in Turkey
-
Sponsored by Gün + PartnersAysel Korkmaz Yatkın and Fatma Sevde Tan of Gün and Partners discuss a welcome decision that reinforces patent owners’ right to information about pharmaceutical licensing applications in Turkey
-
Sponsored by Gün + PartnersÖzge Atılgan Karakulak and Beste Turan of Gün + Partners consider how technological advancement supports the creation of SEPs in Turkey
-
Sponsored by Gün + PartnersBarış Kalaycı, Zeynep Seda Alhas and Begüm Soydan Sayılkan of Gun and Partners explain why brand owners need to take an active role to combat counterfeits in Turkey
-
Sponsored by Gün + PartnersUğur Aktekin and Begüm Soydan Sayılkan of Gün and Partners discuss developments regarding well-known trademarks since the Court of Cassation’s decision in February 2020
